Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES:
Consolidated net loss	$ (1,667,016)	$ (9,194)
Adjustments to reconcile consolidated net loss to Net cash provided by operating activities:
Depreciation and amortization	742,936	716,332
Inventory step-up	281	99,099
Share-based compensation	40,252	44,567
Amortization of debt issuance costs and discount	17,698	21,483
(Benefit) provision for bad debts	(381)	6,264
Provision for inventory reserve	102,003	97,546
Deferred income taxes	(239,174)	(613,318)
Change in fair value of contingent consideration	23,574	24,790
Loss on extinguishment of debt	51,734	0
Asset impairment charges	1,023,930	284,409
(Gain) loss on sale of business and other assets	(5,074)	3,848
Changes in assets and liabilities which (used) provided cash:
Accounts receivable	471,829	342,012
Inventories	(10,956)	(75,331)
Prepaid and other assets	13,526	(289,631)
Accounts payable and accrued expenses	(152,517)	(651,767)
Other liabilities	(6,728)	(250,746)
Income taxes payable/receivable	18,145	693,014
Net cash provided by operating activities	424,062	443,377
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(94,102)	(88,087)
Acquisitions, net of cash acquired	0	(30,394)
Proceeds from sale of marketable securities and investments	0	34
Decrease in notes receivable	7,000	0
Patent acquisition costs and license fees	0	(19,206)
Proceeds from sale of business and other assets, net	96,066	6,686
Increase in restricted cash and cash equivalents	(624,145)	(588,455)
Decrease in restricted cash and cash equivalents	545,379	898,288
Net cash (used in) provided by investing activities	(69,802)	178,866
FINANCING ACTIVITIES:
Proceeds from issuance of notes	300,000	0
Proceeds from issuance of term loans	3,415,000	0
Principal payments on term loans	(3,722,413)	(76,000)
Repayments of revolving debt	0	(225,000)
Principal payments on other indebtedness	(4,912)	(4,634)
Deferred financing fees	(57,358)	(500)
Payment for contingent consideration	(63,712)	(23,807)
Payments of tax withholding for restricted shares	(1,958)	(10,532)
Exercise of options	0	1,952
Issuance of ordinary shares related to the employee stock purchase plan	0	4,010
Net cash used in financing activities	(135,353)	(334,511)
Effect of foreign exchange rate	3,686	1,497
Movement in cash held for sale	(1,450)	0
NET INCREASE IN CASH AND CASH EQUIVALENTS	221,143	289,229
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	517,250	272,348
CASH AND CASH EQUIVALENTS, END OF PERIOD	738,393	561,577
SUPPLEMENTAL INFORMATION:
Cash received from income taxes, net	6,225	702,786
Cash paid into Qualified Settlement Funds for mesh legal settlements	623,128	587,782
Cash paid out of Qualified Settlement Funds for mesh legal settlements	545,379	898,288
Other cash distributions for mesh legal settlements	3,625	5,561
SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrual for purchases of property, plant and equipment	$ 884	$ 2,201